CAS 163521-08-2 Ubunyulu > 99.0% (HPLC) API High Purity

Inkcazelo emfutshane:

CAS: 1761-61-1

Ubunyulu: >99.0% (HPLC)

Imbonakalo: I-White okanye i-Off-White Powder

I-5-HT1A i-Agonist engaphelelanga kunye ne-SSRI enamandla;Amachiza okudakumba

Umgangatho ophezulu we-API, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

AbaPhakathi abaNxulumene noBonelelo loMvelisi
5-Cyanoindole CAS 15861-24-2
3-(4-Chlorobutyl)-5-Cyanoindole CAS 143612-79-7
I-Ethyl 5-Nitrobenzofuran-2-Carboxylate CAS 69604-00-8
Ethyl 5-Aminobenzofuran-2-Carboxylate CAS 174775-48-5
5-(Piperazin-1-yl)benzofuran-2-Carboxamide CAS 183288-46-2
I-CAS 163521-08-2

Iipropati zeMichiza:

Izithethantonye	5-[4-[4-(5-Cyanoindol-3-yl) butyl]piperazin-1-yl]benzofuran-2-Carboxamide Hydrochloride
Inombolo yeCAS	1761-61-1
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C26H28ClN5O2
Ubunzima beMolekyuli	477.98582
Indawo yokunyibilika	279℃ (lit.)
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye oMhlophe
Ukuchongwa	Nge-IR;Nge-HPLC
Isiqulatho samanzi	<1.00%
Intsalela kwi-Ignition	<0.10%
Iintsimbi ezinzima	<20ppm
Izinto ezinxulumeneyo
Nakuphi na Ukungacoceki Okukodwa	<0.50%
Ukungcola ngokupheleleyo	<1.00%
Ubunyulu / Indlela yokuHlalutya	> 99.0% (HPLC) (kwisiseko se-anhydrous)
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	API;Kunyango lwe-Major Depressive Disorder (MDD);Amachiza okudakumba

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-API (i-CAS: i-163521-08-2) i-serotonin edibeneyo ye-reuptake inhibitor (SSRI) kunye ne-5-HT1A ye-receptor inxalenye ye-agonist yonyango lwe-Major Depressive Disorder (MDD).Amachiza okudakumba.Ithengiswa phantsi kwegama lokurhweba i-Viibryd, yaphuhliswa nguMerck KGaA (eJamani) kwaye ivunyiwe kunyango lokudakumba yi-US FDA ngoJanuwari 21st, 2011. Iboniswe ukuba inyamezeleke kakuhle kumanqanaba aphezulu edosi, ngokukodwa ngu. ungabangeli ubunzima obuninzi okanye ukuncipha komnqweno wesini okanye umsebenzi, oluluphuculo kunyango olukhoyo lwe-antidepressant.IShanghai Ruifu Chemical Co., Ltd. ngumenzi okhokelayo kunye nomthengisi wayo kunye nabaphakathi abanxulumene nomgangatho ophezulu.